Relay Therapeutics, Inc. (RLAY) Total liabilities 2020–2025
Relay Therapeutics, Inc. (RLAY) total liabilities at each fiscal year-end, per SEC filings.
$54.3MFY2025 · since FY2020: $36.5M → $54.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.3M | -42.0% |
| FY2024 | $93.5M | +1.7% |
| FY2023 | $92.0M | -38.5% |
| FY2022 | $149.6M | +35.2% |
| FY2021 | $110.6M | +202.8% |
| FY2020 | $36.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More RLAY financial trends
RLAY RevenueRLAY Net incomeRLAY Net marginRLAY Gross profitRLAY Gross marginRLAY Operating incomeRLAY Operating marginRLAY Operating cash flowRLAY Free cash flowRLAY Capital expendituresRLAY Return on equityRLAY Stock buybacksRLAY Dividends paidRLAY Total assetsRLAY Shareholders’ equityRLAY overview →